EIM
HALO icon

Essex Investment Management’s Halozyme HALO Stock Holding History

Essex Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-49,258
Closed -$965K – 409
2018
Q1 		$965K Buy
+49,258
New +$954K 0.13% 216

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Essex Investment Management's HALO Position: Q2 2018 in Review

Essex Investment Management sold out of Halozyme (HALO) in Q2 2018, closing a stake of 49,258 shares — an estimated $965K sold.

Essex Investment Management first reported a position in HALO in Q1 2018 and held it in 1 quarter. The position peaked at $965K in Q1 2018. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

  • Essex Investment Management reported no remaining Halozyme position as of Q2 2018 after selling out during the quarter.
  • Essex Investment Management sold 49,258 Halozyme shares in Q2 2018, an estimated $965K.
  • Essex Investment Management first reported a position in Halozyme in Q1 2018 and held it in 1 quarter.
  • Essex Investment Management's Halozyme position peaked at $965K in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on Essex Investment Management's 13F filing for Q2 2018, filed 17 Jul 2018.